billHR7587Friday, February 13, 2026Analyzed

To amend the National Agricultural Research, Extension, and Teaching Policy Act of 1977 to modify the BARD Fund, and for other purposes.

Neutral
Impact4/10
Agriculture

Summary

HR7587, modifying the BARD Fund, is in the early stages of the legislative process. This bill focuses on agricultural research funding mechanisms, which will impact specific research institutions and agricultural technology developers. No immediate market-wide impact is expected.

Key Takeaways

  • 1.HR7587 modifies the BARD Fund, impacting agricultural research funding.
  • 2.The bill is in the early committee stage, with no immediate market impact.
  • 3.Direct beneficiaries are research institutions, not publicly traded companies at this stage.

Market Implications

This bill has no immediate market implications for publicly traded companies. The focus on agricultural research funding through the BARD Fund primarily affects academic and research institutions. No specific tickers are directly impacted at this legislative stage.

Full Analysis

HR7587, titled 'To amend the National Agricultural Research, Extension, and Teaching Policy Act of 1977 to modify the BARD Fund, and for other purposes,' has been referred to the House Committee on Agriculture. This action signifies the initial step in the legislative process for a bill focused on agricultural research funding. The BARD Fund (Binational Agricultural Research and Development Fund) supports collaborative agricultural research between the United States and Israel. Modifications to this fund will directly influence the types of research projects funded and the institutions receiving grants. The money trail for this bill, if it progresses, will involve direct grants from the BARD Fund to agricultural research institutions and universities. Companies involved in agricultural technology, biotechnology, and specialized farming equipment may see indirect benefits as research advances lead to new products and methods. However, the bill does not specify new appropriations or direct procurement contracts for specific companies at this stage. The primary beneficiaries will be research entities rather than publicly traded corporations. Historically, modifications to agricultural research funding mechanisms have not produced significant, immediate market movements for publicly traded companies. For example, the 2018 Farm Bill, which included various agricultural research provisions, did not cause a discernible surge or decline in major agricultural company stocks like Deere & Company ($DE) or Corteva ($CTVA) upon its passage. The impact is typically long-term and diffused across the agricultural supply chain rather than concentrated in specific stock price movements. The current bill is far less comprehensive than a Farm Bill, further limiting its direct market impact. Specific winners, if the bill passes and increases funding or alters research priorities, will be agricultural research institutions and potentially private companies collaborating on BARD-funded projects. However, without specific funding amounts or direct corporate involvement outlined, no specific publicly traded companies are identified as direct winners or losers at this stage. The bill's current status as 'referred to committee' means it is in the very early stages of legislative consideration. The next step for HR7587 is consideration by the House Committee on Agriculture. The committee may hold hearings, propose amendments, and eventually vote on whether to send the bill to the full House for a vote. This process can take months or even years. No immediate market action is warranted based on this referral.

Market Impact Score

4/10
Minimal ImpactModerateMajor Market Event